Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

National Heart, Lung, and Blood Institute (NHLBI)355 enrolled

Overview

The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in patients with and in patients without atherosclerosis is influenced by prior CMV exposure.

Study Type

OBSERVATIONAL

Enrollment

355

Conditions

Arterial Occlusive Diseases Atherosclerosis Coronary Disease Cytomegalovirus Infections

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Patients who are being evaluated to determine if they have CAD or those who have already been studied and the presence or absence of CAD has been ascertained. No patients who have not been evaluated for CAD.

Locations (1)

National Heart, Lung and Blood Institute (NHLBI)

Bethesda, Maryland, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.